Home

Mixed Treatment Comparisons, Network Meta-Analysis (NMA)

Bayesian statistics, convergence diagnostics

Health Economics Modeling: Cost-Effectiveness, Budget Impact

Markov and semi-Markov models, microsimulation, DICE

Real World Studies (cohorts, databases, SNDS)

Econometrics, flexible and predictive models (spline), bayesian methods, CE-CU model inputs, population, external validation, calibration

Open Data, data science, social networks

Statistical reports, machine learning, modeling, care pathway, process mining (organisational impact)

Welcome!

Statésia is a research and consulting firm specialized in comparative effectiveness research and medico-economic analysis of health technologies and strategies (for hospitals, drug and medical device manusfacturers, consultancy firms, health institutions, HAS DEAI, CT, CEESP, CEPS).

This decision analysis is based on:

1- Comparative Effectiveness Research, Indirect and Mixed Treatment Comparisons (MTC, NMA) : Positioning your innovative technology in the studied therapeutic area;

2- Interactive Health Economics Modeling: Assessing the cost-effectiveness, the cost-utility or the cost-benefit of your innovative health product or technology;

3- Interactive Budget Impact Analysis (IBIA) : Assessing the affordability of your innovative product;

4- Medico-economic real life studies.

News 29

News: Biography written by Le Mans University for Franck MAUNOURY (institutional weblink).

FaLang translation system by Faboba

News

News: Biography written by Le Mans University for Franck MAUNOURY (institutional weblink).

News: Celebrating an Educational Milestone Franck MAUNOURY (PhD, HDR), CEO STATESIA, associate professor, and MSc Health Economics co-founder/co-chair at Le Mans Université (GAINS, IRA), defended a professorial university thesis (HDR), obtained on 29 november 2023 at Le Mans Université (institutional weblink).

Publication: Maunoury F^1,2, Drugeon B³, Boisson M^4,5, Marjanovic N³, Couvreur R^3,4, Mimoz O^3,4,6, Guenezan J^3,4,6, on behalf of the CLEAN-3 Study. Cost-effectiveness analysis of bundled innovative devices versus standard approach in the prevention of unscheduled peripheral venous catheters removal due to complications in France. PLoS One. 2022.

1 Statesia, Le Mans, France; 2 University of Le Mans, GAINS, IRA, Le Mans, France; 3 University Hospital of Poitiers, Emergency Department and Pre-Hospital Care, France; 4 University of Poitiers, School of Medicine and Pharmacy, Poitiers, France; 5 University Hospital of Poitiers, Anesthesia, Intensive Care and Peri-Operative Medicine Department, France; 6 INSERM U1070, Pharmacology of anti-infective drugs, Poitiers, France.

Publication: Maunoury F¹, Oury A², Fortin S², Thomassin L³, Bohbot S³; Explorer Study. Cost-effectiveness of TLC-NOSF dressings versus neutral dressings for the treatment of diabetic foot ulcers in France. PLoS One. 2021 Jan 22;16(1):e0245652. doi: 10.1371/journal.pone.0245652. PMID: 33481840; PMCID: PMC7822547.

1 Health Economics, Statesia, Le Mans, France. 2 Global Regulatory Affairs & Market Access, URGO Medical, Chenôve, France. 3 Global Medical Affairs, URGO Medical, Paris, France.